FIG. 3.
Fasting plasma glucose (A), HbA1c levels (B), and body weight (C) during the study. One month after the treatment, all monkeys in the STZ group developed severe diabetes, and this marked hyperglycemia remained during the study (A and B). There was no significant change in body weight during the study in both control and STZ groups (C). *P < 0.01 vs. control.